Literature DB >> 23238144

Breast cancer management: past, present and evolving.

M Akram1, S A Siddiqui.   

Abstract

Breast cancer is known from ancient time,and the treatment strategy evolved as our understanding of the disease changed with time. In 460 BC Hippocrates described breast cancer as a humoral disease and presently after a lot of studies breast cancer is considered as a local disease with systemic roots. For most of the twentieth century Halsted radical mastectomy was the "established and standardized operation for cancer of the breast in all stages, early or late". New information about tumor biology and its behavior suggested that less radical surgery might be just as effective as the more extensive one. Eventually, with the use of adjuvant therapy likeradiation and systemic therapy, the extent of surgical resection in the breast and axilla got reduced further and led to an era of breast conservation. The radiation treatment of breast cancer has evolved from 2D to 3D Conformal and to accelarated partial breast irradiation, aiming to reduce normal tissue toxicity and overall treatment time. Systemic therapy in the form of hormone therapy, chemotherapy and biological agents is now a well-established modality in treatment of breast cancer. The current perspective of breast cancer management is based on the rapidly evolving and increasingly integrated study on the genetic, molecular , biochemical and cellular basis of disease. The challenge for the future is to take advantage of this knowledge for the prediction of therapeutic outcome and develop therapies and rapidly apply more novel biologic therapeutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238144     DOI: 10.4103/0019-509X.104486

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  10 in total

Review 1.  Current strategies with 2-staged prosthetic breast reconstruction.

Authors:  Christin Harless; Steven R Jacobson
Journal:  Gland Surg       Date:  2015-06

2.  Retrospective observational cohort study on cosmetic outcome of using Ti-Ni memory alloy wire for intradermal suture following mastectomy in patients with breast cancer.

Authors:  Gang Li; Sida Qin; Xin Sun; Jiansheng Wang; Yunfeng Zhang; Jia Zhang; Jing Zhang; Shou-Ching Tang; Hong Ren
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

Review 3.  Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.

Authors:  Mohamed I Nounou; Fatema ElAmrawy; Nada Ahmed; Kamilia Abdelraouf; Satyanarayana Goda; Hussaini Syed-Sha-Qhattal
Journal:  Breast Cancer (Auckl)       Date:  2015-09-27

Review 4.  Drug repurposing for breast cancer therapy: Old weapon for new battle.

Authors:  Sadhna Aggarwal; Sumit Singh Verma; Sumit Aggarwal; Subash Chandra Gupta
Journal:  Semin Cancer Biol       Date:  2019-09-21       Impact factor: 15.707

5.  CircRNA_0044556 diminishes the sensitivity of triple‑negative breast cancer cells to adriamycin by sponging miR‑145 and regulating NRAS.

Authors:  Jingjing Chen; Peng Shi; Jinghua Zhang; Yufeng Li; Jie Ma; Yudong Zhang; Hong Liu
Journal:  Mol Med Rep       Date:  2021-12-16       Impact factor: 2.952

Review 6.  Breast cancer in India: Present scenario and the challenges ahead.

Authors:  Ravi Mehrotra; Kavita Yadav
Journal:  World J Clin Oncol       Date:  2022-03-24

Review 7.  Breast cancer: Muscarinic receptors as new targets for tumor therapy.

Authors:  Alejandro Español; Agustina Salem; Yamila Sanchez; María Elena Sales
Journal:  World J Clin Oncol       Date:  2021-06-24

8.  Differential prognostic indicators for locoregional recurrence, distant recurrence, and death of breast cancer.

Authors:  Rungnapa Chairat; Adisorn Puttisri; Asani Pamarapa; Jirause Moollaor; Chamaiporn Tawichasri; Jayanton Patumanond
Journal:  ISRN Oncol       Date:  2013-11-26

9.  [Place of surgery in the treatment of breast cancer in women at University Hospital Yalgado Ouedraogo: about 81 cases].

Authors:  Nayi Zongo; Timonga Françoise Danielle Millogo-Traore; Sidpawalmdé Carine Bagre; Abdoul-Halim Bagué; Edgar Ouangre; Maurice Zida; Aboubacar Bambara; Tozoula Augustin Bambara; Si Simon Traoré
Journal:  Pan Afr Med J       Date:  2015-10-12

10.  Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II.

Authors:  Sung-Bae Kim; Yau Tsz Kok; Tran Van Thuan; Tsu-Yi Chao; Zhen Zhou Shen
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.